Silence Therapeutics PLC (SLN) — Cash Flow Quality Index
Latest as of December 2024:
-1.09x
Silence Therapeutics PLC (SLN) has a Cash Flow Quality Index of -1.09x as of December 2024. Operating cash flow of $-24.86 Million is below net income of $22.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Silence Therapeutics PLC's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-1.09x
Operating CF / Net Income
Operating Cash Flow
$-24.86 Million
USD
Net Income
$22.89 Million
USD
Data as of
Dec 2024
Most recent filing
Annual Cash Flow Quality Index for Silence Therapeutics PLC (None–None)
Year-by-year earnings quality comparison for Silence Therapeutics PLC. For live market cap and the full company financial profile, see Silence Therapeutics PLC stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.